bf/NASDAQ:VECT_icon.jpeg

NASDAQ:VECT

VectivBio

  • Stock

USD

Last Close

16.85

07/07 19:59

Market Cap

1.06B

Beta: 0.05

Volume Today

127.65K

Avg: 38.14K

PE Ratio

−7.94

PFCF: −18.81

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
net income
-23.48M
-
-59.94M
155.28%
-87.01M
45.15%
-93.73M
7.73%
depreciation and amortization
152K
-
270K
77.63%
303K
12.22%
239K
21.12%
deferred income tax
-617K
-
-394K
36.14%
-76K
80.71%
stock based compensation
2.08M
-
5.45M
161.15%
24.90M
357.32%
16.77M
32.66%
change in working capital
4.97M
-
2.40M
51.80%
1.19M
50.17%
9.50M
695.31%
accounts receivables
inventory
accounts payables
2.99M
-
5.59M
86.84%
-574K
110.26%
-6.78M
1,081.71%
other working capital
1.98M
-
-3.20M
261.76%
1.77M
155.28%
16.28M
820.76%
other non cash items
1.99M
-
14.01M
603.16%
-11.45M
181.72%
10.97M
195.82%
net cash provided by operating activities
-14.90M
-
-38.21M
156.51%
-72.14M
88.79%
-56.26M
22.01%
investments in property plant and equipment
-56K
-
-93K
66.07%
-57K
38.71%
-74K
29.82%
acquisitions net
-1.20M
-
purchases of investments
-4K
-
-7K
75%
sales maturities of investments
other investing activites
15K
-
31K
106.67%
-5.42M
17,577.42%
net cash used for investing activites
-45K
-
-69K
53.33%
-6.67M
9,569.57%
-74K
98.89%
debt repayment
-86K
-
-148K
72.09%
-135K
8.78%
-133K
1.48%
common stock issued
15.35M
-
55.14M
259.22%
154.13M
179.53%
179.21M
16.27%
common stock repurchased
-5K
-
dividends paid
other financing activites
17.55M
-
1.60M
90.89%
-12.66M
892.43%
-4.01M
68.33%
net cash used provided by financing activities
32.81M
-
56.59M
72.46%
141.33M
149.75%
175.06M
23.87%
effect of forex changes on cash
-183K
-
2.05M
1,221.86%
19K
99.07%
-14K
173.68%
net change in cash
17.69M
-
20.36M
15.11%
62.53M
207.16%
118.71M
89.83%
cash at beginning of period
2.13M
-
19.81M
831.94%
40.17M
102.76%
102.71M
155.67%
cash at end of period
19.81M
-
40.17M
102.76%
102.71M
155.67%
221.42M
115.58%
operating cash flow
-14.90M
-
-38.21M
156.51%
-72.14M
88.79%
-56.26M
22.01%
capital expenditure
-56K
-
-93K
66.07%
-57K
38.71%
-74K
29.82%
free cash flow
-14.95M
-
-38.30M
156.17%
-72.20M
88.48%
-56.33M
21.97%

All numbers in USD (except ratios and percentages)